CN1199977C - Simple process for synthesizing 3,6-branched mannopentaose - Google Patents
Simple process for synthesizing 3,6-branched mannopentaose Download PDFInfo
- Publication number
- CN1199977C CN1199977C CN 01110764 CN01110764A CN1199977C CN 1199977 C CN1199977 C CN 1199977C CN 01110764 CN01110764 CN 01110764 CN 01110764 A CN01110764 A CN 01110764A CN 1199977 C CN1199977 C CN 1199977C
- Authority
- CN
- China
- Prior art keywords
- mannose
- mannopentaose
- acetyl
- benzoyl
- mannobiose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 title claims description 6
- YETHWGOYCQLNKG-FHERGOJNSA-N alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-alpha-D-Manp-(1->2)-alpha-D-Manp-(1->2)-D-Manp Chemical compound O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@H]1O[C@@H]1[C@@H](O[C@@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YETHWGOYCQLNKG-FHERGOJNSA-N 0.000 title claims description 6
- 238000000034 method Methods 0.000 title claims description 4
- 230000002194 synthesizing effect Effects 0.000 title 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 17
- -1 propylidene group Chemical group 0.000 claims description 8
- GUBGYTABKSRVRQ-PZPXDAEZSA-N 4β-mannobiose Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-PZPXDAEZSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 6
- 239000002841 Lewis acid Substances 0.000 claims description 6
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 claims description 6
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 6
- 239000000348 glycosyl donor Substances 0.000 claims description 6
- 150000007517 lewis acids Chemical class 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 5
- UPQQXPKAYZYUKO-UHFFFAOYSA-N 2,2,2-trichloroacetamide Chemical compound OC(=N)C(Cl)(Cl)Cl UPQQXPKAYZYUKO-UHFFFAOYSA-N 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 claims description 4
- DRUIESSIVFYOMK-UHFFFAOYSA-N Trichloroacetonitrile Chemical compound ClC(Cl)(Cl)C#N DRUIESSIVFYOMK-UHFFFAOYSA-N 0.000 claims description 3
- 229910015900 BF3 Inorganic materials 0.000 claims description 2
- 239000000370 acceptor Substances 0.000 claims description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 238000006482 condensation reaction Methods 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 239000000937 glycosyl acceptor Substances 0.000 claims description 2
- 150000008146 mannosides Chemical class 0.000 claims description 2
- 150000002905 orthoesters Chemical class 0.000 claims description 2
- 238000010189 synthetic method Methods 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 abstract description 4
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 abstract 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 238000004440 column chromatography Methods 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241001289435 Astragalus brachycalyx Species 0.000 description 3
- 235000002917 Fraxinus ornus Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101150003085 Pdcl gene Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- NLWOKYQYHYOXTK-BFSPYNFASA-N [(2R,3R,4R,5S,6R)-3,4-dibenzoyloxy-5,6-dihydroxyoxan-2-yl]methyl benzoate Chemical compound C(C1=CC=CC=C1)(=O)O[C@@H]1[C@@H]([C@H](O)O[C@@H]([C@H]1OC(C1=CC=CC=C1)=O)COC(C1=CC=CC=C1)=O)O NLWOKYQYHYOXTK-BFSPYNFASA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000386 donor Substances 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical group [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
本发明涉及哺乳动物和寄生虫体内起重要生物学作用的甘露核心五糖α-D-甘露糖1→2-α-D-甘露糖1→6-(α-D-甘露糖1→2-α-D-甘露糖1→3)-D-甘露糖的简便化学合成法。The present invention relates to mannose core pentasaccharide α-D-mannose 1→2-α-D-mannose 1→6-(α-D-mannose 1→2- A simple chemical synthesis of α-D-mannose 1→3)-D-mannose.
Description
本发明属于有生物活性的寡糖的制备领域,特别是涉及能用于药物筛选的寡糖的合成方法。The invention belongs to the field of preparation of biologically active oligosaccharides, in particular to a synthesis method of oligosaccharides which can be used for drug screening.
与天冬酰胺连接的寡糖链简称N-糖链,它通常具有一个含7-9个甘露糖基的甘露寡糖,而这个甘露寡糖总含有一个3,6支化的甘露核心五糖,如下结构式所示The oligosaccharide chain linked to asparagine is referred to as N-sugar chain, which usually has a manno-oligosaccharide containing 7-9 mannosyl groups, and this manno-oligosaccharide always contains a 3, 6-branched manno-core pentasaccharide , as shown in the following structural formula
N-糖链的结构特征为包含有至少一个在甘露糖上3,6支化的寡糖二天线,此外,带有5-9个甘露糖的高甘露糖型N-糖链是复杂型N-糖链合成的前身,故肿瘤糖蛋白中高甘露糖型糖链的出现或增多是提示由于细胞恶性增殖、糖蛋白合成速度增加的需要而致糖链加工不完全、不成熟。合成甘露核心五糖是制备相关抗原或诊断试剂的基础,是糖生物学研究必备的基本原料。另外,甘露核心五糖与CoA的结合可应用于该蛋白的分离提纯,具有潜在的工业应用前景。The structure of N-glycan chains is characterized by at least one oligosaccharide diantennium branched on mannose with 3, 6. In addition, high mannose N-glycan chains with 5-9 mannose are complex type N -The predecessor of sugar chain synthesis, so the appearance or increase of high mannose sugar chains in tumor glycoproteins indicates that the processing of sugar chains is incomplete and immature due to the need for malignant cell proliferation and increased glycoprotein synthesis speed. Synthesis of mannose core pentasaccharide is the basis for the preparation of related antigens or diagnostic reagents, and is an essential raw material for glycobiology research. In addition, the combination of mannocorepentasaccharide and CoA can be applied to the separation and purification of this protein, which has potential industrial application prospects.
本发明的目的在于将上述甘露核心五糖的合成用一步法的模式完成,以1,2-乙叉基-β-D-甘露糖苷为受体,以α1→2连接的甘露双糖三氯乙酰亚胺酯为糖基供体,以路易斯酸为催化剂,简易合成甘露五糖。较已报道的方法大大简化,适于批量制备。The purpose of the present invention is to complete the synthesis of the above-mentioned mannose core pentasaccharide in a one-step method, using 1,2-ethylidene-β-D-mannoside as the acceptor, and mannobiose trichloride linked by α1→2 Acetimide ester is used as sugar group donor, and mannopentaose can be easily synthesized by using Lewis acid as catalyst. Compared with the reported method, it is greatly simplified and suitable for batch preparation.
本发明的合成方法在于:The synthetic method of the present invention is:
以甘露糖苷1为糖基受体,以α1→2连接的甘露双糖三氯乙酰亚胺酯2为糖基供体,一步法缩合成3,6位连接的甘露五糖3,脱掉异丙叉基和乙酰基即得到甘露五糖4。如下反应式所示:Using mannoside 1 as the glycosyl acceptor and α1→2-linked mannobiose trichloroacetimidate 2 as the glycosyl donor, one-step condensation into mannopentaose 3 linked at the 3 and 6 positions, removing the iso The propylidene and acetyl groups give mannopentaose 4. The following reaction formula is shown:
Bz=苯甲酰基,Ac=乙酰基Bz = benzoyl, Ac = acetyl
α1→2连接的甘露双糖三氯乙酰亚胺酯的糖基供体2由甘露糖原酸酯7缩合,得到α1→2连接的甘露双糖8,脱掉烯丙基后再用三氯乙睛活化1位即得到2,而糖的原酸酯7由乙酰基溴代甘露糖5制备,如下反应式所示:The glycosyl donor 2 of the α1→2-linked mannanbiose trichloroacetimide ester was condensed from the mannose orthoester 7 to obtain the α1→2-linked mannanbiose 8, and the allyl group was removed and then trichloro Acetonitrile activates the 1 position to obtain 2, and the orthoester 7 of the sugar is prepared from acetylbromomannose 5, as shown in the following reaction formula:
Bz=苯甲酰基,Ac=乙酰基 All=烯丙基Bz = benzoyl, Ac = acetyl All = allyl
所述的缩合反应需用有机溶剂卤代烷烃,醚或酰胺类做溶剂,需用路易斯酸做催化剂。The condensation reaction needs to use an organic solvent halogenated alkanes, ethers or amides as a solvent, and a Lewis acid as a catalyst.
所用的有机溶剂最好是二氯甲烷,所用的路易斯酸最好是三甲基硅三氟甲磺酸酯或三氟化硼。The organic solvent used is preferably dichloromethane, and the Lewis acid used is preferably trimethylsilyl triflate or boron trifluoride.
下面结合实施例对本发明进行详细的说明。The present invention will be described in detail below in conjunction with the examples.
(1)保护的甘露核心五糖3的合成(1) Synthesis of protected manna core pentasaccharide 3
将1,2乙叉基甘露糖1(1.03克,5毫摩尔),α1→2连接的甘露双糖三氯乙酰亚胺酯的糖基供体2(11.5克,10毫摩尔)溶于100毫升二氯甲烷中,冷却至-10℃,在搅拌下加入三甲基硅三氟甲磺酸酯100微升,然后使反应物自然升温到室温,五小时后加200微升三乙胺结束反应,减压下蒸掉溶剂,柱层析分离后得中间物3(16.5克,77%)。m.p141-144℃;[α]D-11.5°(c1.1,CHCl3);1H NMRδ7.98-7.25(m,60H,Bz-H),5.67(dd,1H,J 3.0Hz,J 1.7Hz),5.64(dd,1H,J 3.1Hz,J 1.7Hz),5.53(s,1H),5.26(q,1H,CH3-CH),5.20(s,1H),5.12(d,1H,J 1.6Hz),5.08(d,1H,J 1.7Hz),5.05(d,1H,J 1.7Hz),2.01(s,3H,CH3CO),2.00(s,3H,CH3CO),1.50(d,3H,CH3-CH).1,2 Ethylidene mannose 1 (1.03 g, 5 mmol), glycosyl donor 2 (11.5 g, 10 mmol) of α1→2-linked mannobiose trichloroacetimide ester was dissolved in 100 In milliliter of dichloromethane, cool to -10°C, add 100 microliters of trimethylsilyl trifluoromethanesulfonate under stirring, then let the reactant naturally warm to room temperature, add 200 microliters of triethylamine after five hours to finish After reaction, the solvent was distilled off under reduced pressure, and intermediate 3 (16.5 g, 77%) was obtained after separation by column chromatography. m.p141-144°C; [α] D -11.5° (c1.1, CHCl 3 ); 1 H NMR δ7.98-7.25 (m, 60H, Bz-H), 5.67 (dd, 1H, J 3.0Hz, J 1.7Hz), 5.64(dd, 1H, J 3.1Hz, J 1.7Hz), 5.53(s, 1H), 5.26(q, 1H, CH 3 -CH), 5.20(s, 1H), 5.12(d, 1H, J 1.6Hz), 5.08(d, 1H, J 1.7Hz), 5.05(d, 1H, J 1.7Hz), 2.01(s, 3H, CH3CO ), 2.00(s, 3H, CH3CO ) , 1.50 (d, 3H, CH 3 -CH).
(2)甘露核心五糖4的合成(2) Synthesis of manna core pentasaccharide 4
将保护的甘露核心五糖3(520毫克,0.26毫摩尔)溶于10毫升90%的三氟乙酸中,在室温下搅拌,用TLC(乙酸乙酯/石油醚 1/1)监测反应,反应完成后减压下蒸掉溶剂,柱层析分离后得中间物,将此中间物溶于50毫升用氨饱和的甲醇中,一周后反应完成,减压下蒸掉溶剂,得到的粉状物用乙酸乙酯洗涤,得到甘露核心五糖4 89毫克,产率69%。The protected manna core pentasaccharide 3 (520 mg, 0.26 mmol) was dissolved in 10 ml of 90% trifluoroacetic acid, stirred at room temperature, monitored by TLC (ethyl acetate/petroleum ether 1/1), the reaction After completion, the solvent was distilled off under reduced pressure, and the intermediate was obtained after separation by column chromatography. The intermediate was dissolved in 50 ml of methanol saturated with ammonia. After one week, the reaction was completed, and the solvent was distilled off under reduced pressure to obtain the powder After washing with ethyl acetate, 489 mg of mannose pentasaccharide was obtained with a yield of 69%.
1H NMR(D2O)δ5.32,5.20,5.15,5.13,4.85. 1 H NMR (D 2 O) δ5.32, 5.20, 5.15, 5.13, 4.85.
(3)3,4,6-三-O-苯甲酰基-β-D-甘露糖1,2-烯丙基原酸酯(7)(3) 3,4,6-tri-O-benzoyl-β-D-mannose 1,2-allyl orthoester (7)
将2,3,4,6-四-O-乙酰基-α-D-甘露糖溴(8.22克,20毫摩尔)加入到烯丙醇(40mL)中,在搅拌下加入2,4-二甲基吡啶(2.3mL,20mmol),反应在室温下进行,用TLC检测(1∶1石油醚/乙酸乙酯).反应完成后,减压下浓缩,残余物悬浮于无水甲醇中MeOH(20mL),加入甲醇钠的甲醇溶液(2M,0.4mL),混合物搅拌过夜,反应完成.将反应液减压浓缩,残余物用柱层析分离,得到粉末状6(4.72g,90%).将6溶于吡啶(30mL)中,在搅拌下滴加苯甲酰氯(8.2mL,70mmol).三小时后反应完成,用常规方法对反应液进行后处理,用柱层析(3/1石油醚/乙酸乙酯)精制得到结晶的化合物7(10.33g,~100%).2,3,4,6-Tetra-O-acetyl-α-D-mannose bromide (8.22 g, 20 mmol) was added to allyl alcohol (40 mL), and 2,4-di Pyridine (2.3mL, 20mmol), the reaction was carried out at room temperature, and detected by TLC (1:1 petroleum ether/ethyl acetate). After the reaction was completed, it was concentrated under reduced pressure, and the residue was suspended in MeOH in anhydrous methanol ( 20 mL), was added methanol solution of sodium methoxide (2M, 0.4 mL), the mixture was stirred overnight, and the reaction was completed. The reaction solution was concentrated under reduced pressure, and the residue was separated by column chromatography to obtain powder 6 (4.72 g, 90%). 6 was dissolved in pyridine (30mL), and benzoyl chloride (8.2mL, 70mmol) was added dropwise under stirring. After three hours, the reaction was complete, and the reaction solution was post-treated by conventional methods, and column chromatography (3/1 petroleum ether/ethyl acetate) to obtain crystalline compound 7 (10.33 g, ~100%).
(4)2-O-乙酰基-3,4,6-三-O-苯甲酰基-α-D-甘露糖-(1→2)-3,4,6-三-O-苯甲酰基-α-D-甘露糖烯丙基苷(8)(4) 2-O-acetyl-3,4,6-tri-O-benzoyl-α-D-mannose-(1→2)-3,4,6-tri-O-benzoyl -α-D-Mannose allyl glycoside (8)
化合物7在高真空下干燥二小时,然后溶于二氯甲烷(80mL)中.在-42℃氮气保护下滴加TMSOTf(100微升),2小时后,TLC(3/1石油醚/乙酸乙酯)指示反应完成.用三乙胺中和,减压浓缩,柱层析精制得到固体的8(6.72 g,66%). m.p 148-150℃;[α]D+3.0°(c 1.3,CHCl3);1H NMRδ8.07-7.33,5.99,5.90-5.85,5.70,5.28-5.18,5.16,5.11,4.61-4.47,4.39-4.36,4.15-4.13,3.95-3.92,2.03.计算值C59H52O18:C,67.56;H,4.96.实测值:C,67.60;H,4.92.Compound 7 was dried under high vacuum for two hours, then dissolved in dichloromethane (80mL). TMSOTf (100 microliters) was added dropwise under nitrogen protection at -42°C. After 2 hours, TLC (3/1 petroleum ether/acetic acid ethyl ester) indicated that the reaction was complete. Neutralized with triethylamine, concentrated under reduced pressure, and purified by column chromatography to obtain 8 as a solid (6.72 g, 66%). mp 148-150°C; [α] D +3.0°(c 1.3 C _ 59 H 52 O 18 : C, 67.56; H, 4.96. Found: C, 67.60; H, 4.92.
(5)2-O-乙酰基-3,4,6-三-O-苯甲酰基-α-D-甘露糖-(1→2)-3,4,6-三-O-苯甲酰基-α-D-甘露糖三氯乙酰亚胺酯(2)将化合物8(524mg,0.5mmol)加入到含乙酸钠(293毫克,3毫摩尔)的90%乙酸(10毫升)中,再加入PdCl2(89毫克,0.5毫摩尔),混合物在室温下搅拌12小时,TLC(2/1石油醚/乙酸乙酯)指示反应完成,用二氯甲烷(30mL)稀释,用水、饱和碳酸氢纳溶液洗涤,减压浓缩有机相,用柱层析精制,得到2-O-乙酰基-3,4,6-三-O-苯甲酰基-α-D-甘露糖-(1→2)-3,4,6-三-O-苯甲酰基-α-D-甘露糖(456mg),将其溶于二氯甲烷(20mL)中,加入CCl3CN(0.1毫升,2毫摩尔)及DBU(14微升,0.18毫摩尔),反应6小时后完成,减压下浓缩反应液,柱层析精制得到结晶的化合物2(473毫克,两步收率90%),m.p 139-142℃;[α]D-1.5°(c 1.1,CHCl3),1HNMRδ8.64,8.02-7.26,6.59,6.09,5.95-5.87,5.70,5.20,4.68-4.48,2.03。计算值C58H48O18Cl3N:C,60.3 1;H,4.16.实测值:C,60.34;H,4.15.(5) 2-O-acetyl-3,4,6-tri-O-benzoyl-α-D-mannose-(1→2)-3,4,6-tri-O-benzoyl -α-D-mannose trichloroacetimidate (2) Compound 8 (524 mg, 0.5 mmol) was added to 90% acetic acid (10 ml) containing sodium acetate (293 mg, 3 mmol), and then PdCl 2 (89 mg, 0.5 mmol), the mixture was stirred at room temperature for 12 hours, TLC (2/1 petroleum ether/ethyl acetate) indicated that the reaction was complete, diluted with dichloromethane (30 mL), diluted with water, saturated sodium bicarbonate The solution was washed, the organic phase was concentrated under reduced pressure, and purified by column chromatography to obtain 2-O-acetyl-3,4,6-tri-O-benzoyl-α-D-mannose-(1→2)- 3,4,6-Tri-O-benzoyl-α-D-mannose (456 mg), dissolved in dichloromethane (20 mL), added CCl3CN (0.1 mL, 2 mmol) and DBU (14 microliters, 0.18 mmol), the reaction was completed after 6 hours, the reaction solution was concentrated under reduced pressure, and purified by column chromatography to obtain crystallized compound 2 (473 mg, two-step yield 90%), mp 139-142 ° C; [α] D -1.5° (c 1.1, CHCl 3 ), 1 H NMR δ 8.64, 8.02-7.26, 6.59, 6.09, 5.95-5.87, 5.70, 5.20, 4.68-4.48, 2.03. Calculated for C 58 H 48 O 18 Cl 3 N: C, 60.3 1; H, 4.16. Found: C, 60.34; H, 4.15.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01110764 CN1199977C (en) | 2001-04-20 | 2001-04-20 | Simple process for synthesizing 3,6-branched mannopentaose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01110764 CN1199977C (en) | 2001-04-20 | 2001-04-20 | Simple process for synthesizing 3,6-branched mannopentaose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1381458A CN1381458A (en) | 2002-11-27 |
| CN1199977C true CN1199977C (en) | 2005-05-04 |
Family
ID=4658824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01110764 Expired - Fee Related CN1199977C (en) | 2001-04-20 | 2001-04-20 | Simple process for synthesizing 3,6-branched mannopentaose |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1199977C (en) |
-
2001
- 2001-04-20 CN CN 01110764 patent/CN1199977C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1381458A (en) | 2002-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kanie et al. | Glycosylation using methylthioglycosides of N-acetylneuraminic acid and dimethyl (methylthio) sulfonium triflate | |
| EP2382226B1 (en) | Process for the synthesis of l-fucosyl di- or oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof | |
| CN103958537A (en) | Synthesis of HMO core structures | |
| Tatai et al. | An efficient synthesis of L-idose and L-iduronic acid thioglycosides and their use for the synthesis of heparin oligosaccharides | |
| JP2546659B2 (en) | Method for producing podophyllotoxin type compound | |
| FI79328C (en) | REFERENCE TO A FRAMEWORK FOR OLIGOGALACTOS AND OIL PRODUCTS | |
| Wang et al. | Assembly of a β-(1→ 3)-glucan laminarihexaose on ionic liquid support | |
| Zhu et al. | A facile and effective synthesis of α-(1→ 6)-linked mannose di-, tri-, tetra-, hexa-, octa-, and dodecasaccharides, and β-(1→ 6)-linked glucose di-, tri-, tetra-, hexa-, and octasaccharides using sugar trichloroacetimidates as the donors and unprotected or partially protected glycosides as the acceptors | |
| Hashihayata et al. | Convergent total syntheses of oligosaccharides by one-pot sequential stereoselective glycosylations | |
| Wessel et al. | Strategies for the synthesis of branched oligosaccharides of the Shigella flexneri 5a, 5b, and variant X serogroups employing a multifunctional rhamnose precursor | |
| JP2016537349A (en) | Disaccharide intermediate and synthesis method thereof | |
| Jain et al. | Chemical synthesis of a hexasaccharide comprising the Lewisx determinant linked β-(1→ 6) to a linear trimannosyl core and the precursor pentasaccharide lacking fucose | |
| CN1199977C (en) | Simple process for synthesizing 3,6-branched mannopentaose | |
| Wessel et al. | Articial carbohydrate antigens: A block synthesis of a linear, tetrasaccharide repeating-unit of the Shigella flexneri varianty polysaccharide | |
| Reddy et al. | Synthesis of precursors for the dimeric 3-O-SO3Na Lewis X and Lewis A structures | |
| CN114891049B (en) | An efficient glycosylation method based on o-alkynyl benzyl ether glycosyl donors | |
| Takatani et al. | Synthesis of N-linked pentasaccharides with isomeric glycosidic linkage | |
| CN1324798A (en) | Synthesis of mannitose-glucose tetrasaccharide repeated unit with anti-tumor activity | |
| Garegg et al. | Synthetic mucin fragments: 2-(p-trifluoroacetamidophenyl) ethyl 2-acetamido-6-O-(2-acetamido-2-deoxy-β-d-glucopyranosyl)-2-deoxy-3-O-(β-d-galactopyranosyl)-α-d-galactopyranoside and 2-(p-trifluoroacetamidophenyl) ethyl 2-acetamido-6-O-[2-acetamido-2-deoxy-4-O-(β-d-galactopyranosyl)-β-d-glucopyranosyl]-2-deoxy-3-O-(β-d-galactopyranosyl)-α-d-galactopyranoside | |
| Maeda et al. | Synthetic Studies on Sialoglycoconjugates 71: Synthesis of Sulfo-and Sialyl-Lewis× Epitope Analogs Containing the 1-Deoxy-N-acetylgulcosamine in Place of N-Acetylglucosamine Residue | |
| Miranda et al. | Ferric chloride: a mild and versatile reagent for the formation of 1, 6-anhydro glucopyranoses | |
| Zong et al. | Convenient synthesis of sulfated oligofucosides | |
| Ma et al. | Synthesis of two oligosaccharides, the GPI anchor glycans from S. cerevesiae and A. fumigatus | |
| Feng et al. | Synthesis of a Forssman antigen derivative for use in a conjugate vaccine | |
| Byramova et al. | 1, 6-anhydro-N-acetyl-β-D-glucosamine in oligosaccharide synthesis: II. The synthesis of the spacered Ley tetrasaccharide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |